Best treatments for rheumatoid arthritis
Pro Research Analysisby 
Searched over 200M research papers
Conventional Treatments for Rheumatoid Arthritis: NSAIDs, Glucocorticoids, and DMARDs
The main treatments for rheumatoid arthritis (RA) include nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, and disease-modifying antirheumatic drugs (DMARDs) 125610. NSAIDs and glucocorticoids are effective for managing pain, inflammation, and stiffness, but only DMARDs can slow or stop the progression of joint damage 12510. Conventional synthetic DMARDs, such as methotrexate, hydroxychloroquine, sulfasalazine, and leflunomide, are typically used as first-line therapy for newly diagnosed RA 1256. Early and aggressive use of these drugs, often in combination, is recommended to achieve better long-term outcomes and prevent joint destruction 12568.
Biologic and Targeted Synthetic DMARDs: Advanced and Personalized Approaches
For patients who do not respond adequately to conventional DMARDs, biologic DMARDs and targeted synthetic DMARDs are available 2356789. Biologic DMARDs include tumor necrosis factor (TNF) inhibitors (such as infliximab, etanercept, and adalimumab), interleukin-1 and interleukin-6 inhibitors, B cell depleting agents (like rituximab), and co-stimulation blockers (such as abatacept) 13578. Targeted synthetic DMARDs, such as Janus kinase (JAK) inhibitors, offer another option for patients with moderate to severe disease 579. These advanced therapies are often used in combination with conventional DMARDs for patients with high disease activity or those who are seronegative and do not respond to initial treatments 2568.
Challenges and Unmet Needs: Non-Responders and Difficult-to-Treat RA
Despite the availability of multiple drug classes, 5-20% of RA patients do not respond to any current medications, including biologic and targeted therapies 489. Factors such as genetic markers, comorbidities, and environmental influences (like smoking and diet) can affect treatment response and disease progression . Personalized treatment strategies, including patient profiling and early identification of inadequate responders, are important for optimizing outcomes 2489. There is ongoing research into new therapeutic targets and approaches, such as gene therapy, mesenchymal stem cell therapy, and novel small molecules, to address these unmet needs 27910.
Lifestyle and Environmental Factors in RA Management
In addition to pharmacological treatments, lifestyle and environmental factors can influence RA outcomes. A Mediterranean diet, low salt intake, physical activity, and avoidance of smoking may have beneficial effects on disease activity and overall health, although more research is needed to confirm their efficacy in RA .
Conclusion
The best treatments for rheumatoid arthritis involve a combination of early, aggressive use of conventional DMARDs, with the addition of biologic or targeted synthetic DMARDs for patients who do not respond adequately. Personalized approaches and ongoing research into new therapies are essential for managing difficult-to-treat cases and improving patient outcomes. Lifestyle modifications may also play a supportive role in comprehensive RA management 12345678+2 MORE.
Sources and full results
Most relevant research papers on this topic